What is type 2 diabetes?

Medicine (United Kingdom)

Volumn 42, Issue 12, 2014, Pages 687-691

  Shah, Meera ^a   Vella, Adrian ^a  

^a MAYO CLINIC   (United States)

Author keywords

Incretin hormones; insulin action; insulin secretion; pre diabetes; type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ATYPICAL ANTIPSYCHOTIC AGENT; IMMUNOSUPPRESSIVE AGENT; METFORMIN;

ANTIVIRAL THERAPY; BARIATRIC SURGERY; DISEASE ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; REVIEW;

EID: 84920030730     PISSN: 13573039     EISSN: 13654357     Source Type: Journal    
DOI: 10.1016/j.mpmed.2014.09.013     Document Type: Review

References (39)

1. S.F. Dinneen, D. Maldonado 3rd, and C.L. Leibson Effects of changing diagnostic criteria on the risk of developing diabetes Diabetes Care 21 1998 1408 1413
2. P. Shah, A. Vella, A. Basu, R. Basu, W.F. Schwenk, and R.A. Rizza Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus J Clin Endocrinol Metab 85 2000 4053 4059
3. M.R. Hayden, and J.R. Sowers Isletopathy in type 2 diabetes mellitus: implications of islet RAS, islet fibrosis, islet amyloid, remodeling, and oxidative stress Antioxid Redox Signal 9 2007 891 910
4. R.A. Ritzel, A.E. Butler, R.A. Rizza, J.D. Veldhuis, and P.C. Butler Relationship between beta-cell mass and fasting blood glucose concentration in humans Diabetes Care 29 2006 717 718
5. Y. Saisho, A.E. Butler, and J.J. Meier Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes Clin Anat 20 2007 933 942
6. B.A. Blomberg, I. Codreanu, G. Cheng, T.J. Werner, and A. Alavi Beta-cell imaging: call for evidence-based and scientific approach Mol Imaging Biol 15 2013 123 130
7. N. Pørksen, M. Hollingdal, C. Juhl, P. Butler, J.D. Veldhuis, and O. Schmitz Pulsatile insulin secretion: detection, regulation, and role in diabetes Diabetes 51 suppl 1 2002 S245 S254
8. S. O'Rahilly, R.C. Turner, and D.R. Matthews Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes N Engl J Med 318 1988 1225 1230
9. J.C. Florez, K.A. Jablonski, and N. Bayley TCF7L2 polymorphisms and progression to diabetes in the diabetes prevention program N Engl J Med 355 2006 241 250
10. G. Bock, C. Dalla Man, and M. Campioni Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance Diabetes 55 2006 3536 3549
11. A. Sathananthan, C. Dalla Man, and A.R. Zinsmeister A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations Clin Endocrinol 76 2012 212 219
12. G. Smushkin, and A. Vella Genetics of type 2 diabetes Curr Opin Clin Nutr Metab Care 13 2010 471 477
13. T. Vilsbøll, T. Krarup, C.F. Deacon, S. Madsbad, and J.J. Holst Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients Diabetes 50 2001 609 613
14. M.B. Toft-Nielsen, M.B. Damholt, and S. Madsbad Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients J Clin Endocrinol Metab 86 2001 3717 3723
15. E. Muscelli Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients Diabetes 57 2008 1340 1348
16. M. Laakso, A. Mari, and A. Casolaro Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study Diabetologia 51 2008 502 511
17. A. Fritsche, N. Stefan, E. Hardt, H. Häring, and M. Stumvoll Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion Diabetologia 43 2000 852 858
18. W.C. Knowler, E. Barrett-Connor, and S.E. Fowler Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
19. K.F. Eriksson, and F. Lindgarde Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study Diabetologia 34 1991 891 898
20. E.W. Gregg, H. Chen, and L.E. Wagenknecht Association of an intensive lifestyle intervention with remission of type 2 diabetes JAMA 308 2012 2489 2496
21. A.H. Xiang, R.K. Peters, and S.L. Kjos Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes Diabetes 55 2006 517 522
22. T.A. Buchanan, A.H. Xiang, and R.K. Peters Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women Diabetes 51 2002 2796 2803
23. J. Weng, Y. Li, and W. Xu Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial Lancet 371 2008 1753 1760
24. G.E. Umpierrez, D. Smiley, and A.E. Kitabchi Narrative review: ketosis-prone type 2 diabetes mellitus Ann Intern Med 144 2006 350 357
25. S. Ikramuddin, J. Korner, and W.J. Lee Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the diabetes surgery study JAMA 309 2013 2240 2249
26. C. Jackness, W. Karmally, and G. Febres Very low calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and beta-cell function in type 2 diabetic patients Diabetes 62 2013 3027 3032
27. M. Shah, J.H. Law, and F. Micheletto The contribution of endogenous glucagon-like peptide-1 to glucose metabolism after Roux-en-Y gastric bypass Diabetes 63 2014 483 493
28. M.C. Gulliford, J. Charlton, and R. Latinovic Risk of diabetes associated with prescribed glucocorticoids in a large population Diabetes Care 29 2006 2728 2729
29. R.A. Rizza, L.J. Mandarino, and J.E. Gerich Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action J Clin Endocrinol Metab 54 1982 131 138
30. A.J. Scheen, and M.A. De Hert Abnormal glucose metabolism in patients treated with antipsychotics Diabetes Metab 33 2007 169 175
31. D.E. Johnson, H. Yamazaki, and K.M. Ward Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia Diabetes 54 2005 1552 1558
32. K.A. Bodziak, and D.E. Hricik New-onset diabetes mellitus after solid organ transplantation Transpl Int 22 2009 519 530
33. T. Yagisawa, K. Takahashi, S. Teraoka, H. Toma, T. Agishi, and K. Ota Effects of cyclosporine on glucose metabolism in kidney transplant recipients and rats Transplant Proc 19 1987 1801 1803
34. J.H. Nielsen, T. Mandrup-Poulsen, and J. Nerup Direct effects of cyclosporin a on human pancreatic beta-cells Diabetes 35 1986 1049 1052
35. B.L. Kasiske, J.J. Snyder, D. Gilbertson, and A.J. Matas Diabetes mellitus after kidney transplantation in the United States Am J Transplant 3 2003 178 185
36. H.J. Woerle, P.R. Mariuz, and C. Meyer Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens Diabetes 52 2003 918 925
37. E. Resmini, F. Minuto, A. Colao, and D. Ferone Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities Acta Diabetol 46 2009 85 95
38. G. Stenstrom, L. Sjostrom, and U. Smith Diabetes mellitus in phaeochromocytoma. Fasting blood glucose levels before and after surgery in 60 patients with phaeochromocytoma Acta Endocrinol (Copenh) 106 1984 511 515
39. S. Umeda, K. Ito, and Y. Tsujita Severe hypoglycemia after resection of adrenal pheochromocytoma: a case report Hinyokika Kiyo 55 2009 123 127